Stem Cells International (Jan 2020)

Human Adipose Derived Cells in Two- and Three-Dimensional Cultures: Functional Validation of an In Vitro Fat Construct

  • Robert Bender,
  • Michelle McCarthy,
  • Theodore Brown,
  • Joanna Bukowska,
  • Stanley Smith,
  • Rosalyn D. Abbott,
  • David L. Kaplan,
  • Christopher Williams,
  • James W. Wade,
  • Andrea Alarcon,
  • Xiying Wu,
  • Frank Lau,
  • Jeffrey M. Gimble,
  • Trivia Frazier

DOI
https://doi.org/10.1155/2020/4242130
Journal volume & issue
Vol. 2020

Abstract

Read online

Obesity, defined as a body mass index of 30 kg/m2 or above, has increased considerably in incidence and frequency within the United States and globally. Associated comorbidities including cardiovascular disease, type 2 diabetes mellitus, metabolic syndrome, and nonalcoholic fatty liver disease have led to a focus on the mechanisms promoting the prevention and treatment of obesity. Commonly utilized in vitro models employ human or mouse preadipocyte cell lines in a 2-dimensional (2D) format. Due to the structural, biochemical, and biological limitations of these models, increased attention has been placed on “organ on a chip” technologies for a 3-dimensional (3D) culture. Herein, we describe a method employing cryopreserved primary human stromal vascular fraction (SVF) cells and a human blood product-derived biological scaffold to create a 3D adipose depot in vitro. The “fat-on-chip” 3D cultures have been validated relative to 2D cultures based on proliferation, flow cytometry, adipogenic differentiation, confocal microscopy/immunofluorescence, and functional assays (adipokine secretion, glucose uptake, and lipolysis). Thus, the in vitro culture system demonstrates the critical characteristics required for a humanized 3D white adipose tissue (WAT) model.